ストックスクリーナーアプリを入手
0.5401
1.94%
-0.0107
アフターアワーズ：
.54
-0.000100
-0.02%
前日終値:
$0.5508
開ける：
$0.5401
24時間の取引高:
24,326
Relative Volume:
0.08
時価総額：
$1.49M
収益：
-
当期純損益:
$-2.86M
株価収益率:
-0.2154
EPS:
-2.5071
ネットキャッシュフロー:
$-2.57M
1週間 パフォーマンス:
-4.98%
1か月 パフォーマンス:
-17.54%
6か月 パフォーマンス:
-55.73%
1年 パフォーマンス:
-74.64%
1日の値動き範囲:
$0.54
$0.5681
1週間の範囲:
$0.54
$0.5899
52週間の値動き範囲:
$0.54
$2.89
Bone Biologics Corp Stock (BBLG) Company Profile
名前
Bone Biologics Corp
セクター
電話
(781) 552-4452
住所
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
0.5401 | 1.52M | 0 | -2.86M | -2.57M | -2.5071 |
VRTX
Vertex Pharmaceuticals Inc
|
519.51 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.74 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
990.54 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
146.69 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
205.11 | 43.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Bone Biologics Corp (BBLG) 最新ニュース
Bone Biologics expands Australian trial to six hospital sites - Investing.com Australia
Bone Biologics expands Australian trial to six hospital sites By Investing.com - Investing.com UK
Six Australian hospitals agree to join Bone Biologics' bone-graft trial - Stock Titan
BBLGW 8-K FilingsBone Biologics Corp Warrants SEC 8-K - Stock Titan
A company developing bone products will meet investors in New York - Stock Titan
Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
Bone Biologics (NASDAQ: BBLGW) Schedules Six Key Proposals for September 28 Shareholder Vote - Kalkine Media
Bone Biologics Corp Warrants (BBLGW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Bone Biologics Corp Warrants (BBLGW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Orthobiologics Market Report Examines Leading Companies And Growth Opportunities - openPR.com
Bone Biologics (NASDAQ:BSPK): What Could Its Scheduled Update Reveal? - kalkinemedia.com
Bone (BBLG): Finishes 3.47% Higher at $0.63 in Latest Trading; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance for the Current SessionETF Outflow Streak - vinanet.vn
Bone (BBLGW): Shows Minimal Net Change at $8.24 in Latest Trading; Chart Watch: the Supplied Trading Band Runs From $7.83 to $8.65 under the Current SnapshotPut Flow Alert - siam.in
Bone (BBLG) Chart: Finishes 3.47% Lower at $0.62 for the Current Session; the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotVolume Climax - vinanet.vn
Bone (BBLG) Results and Estimates: The Bottom-Line Figure Outpaces Its Comparison in the Current Update; Post-Report Move: The Stock Ends Down 2.58% in the Latest SessionEPS Growth Report - vinanet.vn
Bone Biologics (NASDAQ: BBLG) seeks 1-for-2 to 1-for-10 reverse split approval - Stock Titan
Price to sales forward of Bone Biologics Corp – NASDAQ:BBLGW - TradingView
Number of shareholders of Bone Biologics Corp – NASDAQ:BBLGW - tradingview.com
Bone Biologics Corp (BBLG) Slips 2.86% as Shares Test Key Support at $0.63Systematic Flow - vinanet.vn
BBLGW Warrants Hold Flat at $7.05 as Bone Biologics Consolidates Between $6.7 and $7.4Volatility Breakout Picks - vinanet.vn
Bone Biologics Raises $2.7M, Extends Cash Runway to Q2 2027 - Minichart
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Bone Biologics Warrants (BBLGW) Hold at $3.50 as Traders Eye Tight RangeEquity Put Call - dars.gov.et
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Bone Biologics Corporation Achieves 32-Month Validated Shelf Life For rhNELL-1 - marketscreener.com
Bone Biologics Corp expected to post a loss of 39 cents a shareEarnings Preview - TradingView
BBLG Q1 2026 Earnings: Narrower-Than-Expected Loss of -$0.43, Though Shares Slip 5.67%Performance Review - vinanet.vn
Bone Biologics Corp (BBLG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
US: Halma sells NovaBone to Keensight-backed Isto Biologics for US$60m - Investors in Healthcare
Bone Biologics Warrants (BBLGW) Steady at $8.0 as Tight Trading Range Takes ShapeWyckoff Spring - vinanet.vn
Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone - Orthopedics This Week
Isto Biologics Acquires NovaBone | Press Release - ACCESS Newswire
Bone Biologics Warrants (BBLGW) Hold Flat at $8.00 as Range-Bound Trading PersistsMA Cross Alert - dars.gov.et
Bone Biologics (BBLG) Dips 3.23% to $0.85 — Shares Approach Key Support at $0.81Money Flow - vinanet.vn
Bone Biologics Corp Warrants (BBLGW) Hold Steady at $8.0 Amid Low Volume ConsolidationSell Signal Alerts - vinanet.vn
Bone Biologics Corp (BBLG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp Warrants (BBLGW) Holds Steady at $8.0 as Consolidation Pattern EmergesMESA MA - po-news-eg.net
Bone Biologics Corp (BBLG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bone Biologics Corp SEC Filing (Jul 27, 2026) - Stock Titan
Bone Biologics Corp (BBLG) Cash Flow - TradingKey
Bone Biologics Corp (BBLG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bone Biologics Corp (BBLG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BBLG|Bone Biologics Corp|Price:1.070|Chg%:-0.010 - TradingKey
BBLG|Bone Biologics Corp|Price:1.010|Chg%:-0.060 - TradingKey
Bone Biologics Corp (BBLG) Nears Support as Selling Pressure PersistsFactor Timing - vinanet.vn
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLGW - tradingview.com
TradingKey - TradingKey
BBLG Q1 2026 Earnings: Narrowed Loss Beats Estimates, But Stock DeclinesProfit Cycle Analysis - Vinanet
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) 財務データ
収益
当期純利益
現金流量
EPS
0.75%
3.18%
大文字化:
|
ボリューム (24 時間):